3-Bromo-7-Nitroindazole

CAS No. 74209-34-0

3-Bromo-7-Nitroindazole( —— )

Catalog No. M15833 CAS No. 74209-34-0

3-Bromo-7-Nitroindazole is a more potent inhibitor of nNOS than 7-nitroindazole in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 Get Quote
25MG 63 Get Quote
50MG 110 Get Quote
100MG 178 Get Quote
200MG 267 Get Quote
500MG 460 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3-Bromo-7-Nitroindazole
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Bromo-7-Nitroindazole is a more potent inhibitor of nNOS than 7-nitroindazole in vitro.
  • Description
    3-Bromo-7-Nitroindazole is a more potent inhibitor of nNOS than 7-nitroindazole in vitro, is also potent against iNOS, inhibits rat nNOS, bovine eNOS, and rat iNOS with IC50 of 0.17, 0.86, and 0.29 uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    NOS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    74209-34-0
  • Formula Weight
    242.032
  • Molecular Formula
    C7H4BrN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (413.17 mM)
  • SMILES
    C1=CC2=C(NN=C2C(=C1)[N+](=O)[O-])Br
  • Chemical Name
    3-bromo-7-nitro-1H-indazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gammie SC, et al. Brain Res. 2000 Jul 7;870(1-2):80-6. 2. Gocmez SS, et al. Pharmacol Biochem Behav. 2015 Apr;131:19-25. 3. Widdowson PS, et al. Br J Pharmacol. 1996 Apr;117(8):1761-7. 4. Vaupel DB, et al. Eur J Pharmacol. 1997 Apr 11;324(1):11-20.
molnova catalog
related products
  • Dehydroeburicoic aci...

    Dehydroeburicoic acid induces necrotic cell death that involves Ca(2+) overload mitochondrial dysfunction and calpain activation in human glioblastomas.

  • Syringin

    Syringin has antitumour, antiproliferative, immunomodulatory and platelet aggregation inhibiting effects. Syringin can prevent Abeta(25-35)-induced neuronal cell damage.

  • CAT639

    CAT639 is an improved analog of ATV399 that exhibits improved β-cell viability and insulin secretion in the rat insulin-producing INS1E cells and primary rat dispersed islet cells.